EXICURE, INC. Earnings Per Share (Basic)
EXICURE, INC. (XCUR) reported Earnings Per Share (Basic) of -$0.18 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-14
- EXICURE, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.18.
- EXICURE, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.29, a 159.18% decline year-over-year.
- EXICURE, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.39.
- EXICURE, INC. earnings per share, basic for the quarter ending 2025-06-30 was -$0.41.
- EXICURE, INC. earnings per share, basic for fiscal 2025 was -$0.79.
- EXICURE, INC. earnings per share, basic for fiscal 2024 was -$4.75.
- EXICURE, INC. earnings per share, basic for fiscal 2023 was -$10.55.
- EXICURE, INC. earnings per share, basic for fiscal 2022 was -$0.56.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.18 10-Q · filed 2026-08-14 | -$0.46 10-Q · filed 2026-08-14 | ||||||
| 2026-03-31 | -$0.29 10-Q · filed 2026-05-29 | |||||||
| 2025-12-31 | -$0.79 10-K · filed 2026-03-25 | |||||||
| 2025-09-30 | -$0.39 10-Q · filed 2025-11-07 | -$0.33 10-Q · filed 2025-11-07 | ||||||
| 2025-06-30 | -$0.41 10-Q · filed 2026-08-14 | $0.06 10-Q · filed 2026-08-14 | ||||||
| 2025-03-31 | $0.49 10-Q · filed 2026-05-29 | |||||||
| 2024-12-31 | -$4.75 10-K · filed 2026-03-25 | |||||||
| 2024-09-30 | -$0.57 10-Q · filed 2025-11-07 | -$1.36 10-Q · filed 2025-11-07 | ||||||
| 2024-06-30 | -$0.35 10-Q · filed 2025-08-08 | -$0.07 10-Q · filed 2024-08-13 | -$0.83 10-Q · filed 2025-08-08 | -$0.17 10-Q · filed 2024-08-13 | ||||
| 2024-03-31 | -$0.48 10-Q · filed 2025-06-27 | -$0.10 10-Q · filed 2024-06-17 | ||||||
| 2023-12-31 | -$10.55 10-K · filed 2025-03-18 | -$2.11 10-K · filed 2024-06-06 | ||||||
| 2023-09-30 | -$3.04 10-Q · filed 2024-11-14 | -$0.61 10-Q · filed 2024-05-16 | -$9.89 10-Q · filed 2024-11-14 | -$1.98 10-Q · filed 2024-05-16 | ||||
| 2023-06-30 | -$0.68 10-Q · filed 2024-08-13 | -$1.38 10-Q · filed 2024-08-13 | ||||||
| 2023-03-31 | -$0.70 10-Q · filed 2024-06-17 | |||||||
| 2022-12-31 | -$0.56 10-K · filed 2024-06-06 | |||||||
| 2022-09-30 | -$1.04 10-Q · filed 2024-05-16 | -$4.66 10-Q · filed 2024-05-16 | ||||||
| 2022-06-30 | -$1.66 10-Q/A · filed 2024-06-06 | -$3.71 10-Q/A · filed 2024-06-06 | ||||||
| 2022-03-31 | -$2.07 10-Q/A · filed 2024-06-06 | -$0.07 10-Q · filed 2022-05-16 | ||||||
| 2021-12-31 | -$21.70 10-K · filed 2023-03-27 | -$0.72 10-K · filed 2022-03-25 | ||||||
| 2021-09-30 | -$8.01 10-Q · filed 2022-11-14 | -$0.27 10-Q · filed 2021-11-19 | -$17.14 10-Q · filed 2022-11-14 | -$0.57 10-Q · filed 2021-11-19 | ||||
| 2021-06-30 | -$4.86 10-Q · filed 2022-08-15 | -$0.16 10-Q · filed 2021-08-12 | -$9.12 10-Q · filed 2022-08-15 | -$0.30 10-Q · filed 2021-08-12 | ||||
| 2021-03-31 | -$0.14 10-Q · filed 2022-05-16 | |||||||
| 2020-12-31 | -$0.15 10-K · filed 2021-03-11 | -$0.28 10-K · filed 2022-03-25 | ||||||
| 2020-09-30 | -$0.10 10-Q · filed 2021-11-19 | -$0.14 10-Q · filed 2021-11-19 | ||||||
| 2020-06-30 | -$0.05 10-Q · filed 2021-08-12 | -$0.04 10-Q · filed 2021-08-12 | ||||||
| 2020-03-31 | $0.01 10-Q · filed 2021-05-12 | |||||||
| 2019-03-31 | -$0.12 10-Q · filed 2020-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |